Correlation Between Inhibikase Therapeutics and Quoin Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Inhibikase Therapeutics and Quoin Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibikase Therapeutics and Quoin Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibikase Therapeutics and Quoin Pharmaceuticals Ltd, you can compare the effects of market volatilities on Inhibikase Therapeutics and Quoin Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibikase Therapeutics with a short position of Quoin Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibikase Therapeutics and Quoin Pharmaceuticals.
Diversification Opportunities for Inhibikase Therapeutics and Quoin Pharmaceuticals
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between Inhibikase and Quoin is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Inhibikase Therapeutics and Quoin Pharmaceuticals Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quoin Pharmaceuticals and Inhibikase Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibikase Therapeutics are associated (or correlated) with Quoin Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quoin Pharmaceuticals has no effect on the direction of Inhibikase Therapeutics i.e., Inhibikase Therapeutics and Quoin Pharmaceuticals go up and down completely randomly.
Pair Corralation between Inhibikase Therapeutics and Quoin Pharmaceuticals
Considering the 90-day investment horizon Inhibikase Therapeutics is expected to generate 0.68 times more return on investment than Quoin Pharmaceuticals. However, Inhibikase Therapeutics is 1.48 times less risky than Quoin Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Quoin Pharmaceuticals Ltd is currently generating about -0.03 per unit of risk. If you would invest 134.00 in Inhibikase Therapeutics on November 2, 2024 and sell it today you would earn a total of 58.00 from holding Inhibikase Therapeutics or generate 43.28% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibikase Therapeutics vs. Quoin Pharmaceuticals Ltd
Performance |
| Timeline |
| Inhibikase Therapeutics |
| Quoin Pharmaceuticals |
Inhibikase Therapeutics and Quoin Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibikase Therapeutics and Quoin Pharmaceuticals
The main advantage of trading using opposite Inhibikase Therapeutics and Quoin Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibikase Therapeutics position performs unexpectedly, Quoin Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quoin Pharmaceuticals will offset losses from the drop in Quoin Pharmaceuticals' long position.| Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Milestone Pharmaceuticals | Inhibikase Therapeutics vs. Seres Therapeutics | Inhibikase Therapeutics vs. Oncolytics Biotech |
| Quoin Pharmaceuticals vs. Revelation Biosciences | Quoin Pharmaceuticals vs. Virax Biolabs Group | Quoin Pharmaceuticals vs. Allarity Therapeutics | Quoin Pharmaceuticals vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |